Study Design of Motion: a 24-Week, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Safinamide in Early Parkinson's Disease - Ongoing Clinical Trial
14Th Congress of European-Federation-Of-Neurological-Societies, Date: SEP, 2010, Location: Geneva, SWITZERLAND, Patrocinadores: European Federat Neurol Soc